Poly Medicure schedules investor meet with Wasatch, Bajaj on Aug 20
Poly Medicure Limited will hold virtual one-on-one investor meetings on August 20, 2026. The sessions include Wasatch Global at 6:30 pm and Bajaj Alternative Investment Ltd at 12:00 pm. The disclosure was made under SEBI LODR Regulation 30, with no unpublished price-sensitive information to be shared.

*this image is generated using AI for illustrative purposes only.
Poly Medicure Limited has scheduled one-on-one virtual meetings with investors and analysts for August 20, 2026. The company disclosed the schedule in a filing dated August 17, 2026, addressed to the listing departments of BSE Limited and National Stock Exchange of India Limited.
The engagements are being held pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III Part A. Poly Medicure stated that no unpublished price-sensitive information would be shared during these interactions.
Meeting Schedule
The company confirmed two separate one-on-one sessions on August 20, 2026. Both meetings will be conducted virtually.
| Participant | Time (India) | Format |
|---|---|---|
| Bajaj Alternative Investment Ltd | 12:00 pm | One-to-One |
| Wasatch Global | 6:30 pm | One-to-One |
Poly Medicure noted that the schedule is subject to change due to exigencies on the part of the analysts, investors, or the company. The details are also available on the company’s website.
Historical Stock Returns for Poly Medicure
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.94% | +2.35% | +4.16% | +33.27% | -8.87% | +97.49% |
How might the specific focus areas of Bajaj Alternative Investment and Wasatch Global influence Poly Medicure's strategic priorities for the upcoming fiscal year?
What impact could the insights shared in these one-on-one sessions have on Poly Medicure's stock valuation and institutional investor confidence?
Are there any pending regulatory approvals or product launches that Poly Medicure is likely to address during these investor engagements?


































